In vitro Inhibition of CYP3A4 by the multiherbal commercial product sambucus force and its main constituents echinacea purpurea and sambucus nigra

Phytotherapy Research

Volumn 26, Issue 11, 2012, Pages 1606-1613

  Schrøder Aasen, Torstein ^a   Molden, Guri ^a   Nilsen, Odd Georg ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

CYP3A4; Echinacea; metabolic interactions; Sambucus

Indexed keywords

CYTOCHROME P450 3A4; ECHINACEA PURPUREA EXTRACT; ECHINAFORCE; KETOCONAZOLE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SAMBUCUS NIGRA EXTRACT; TESTOSTERONE; UNCLASSIFIED DRUG;

ARTICLE; DRUG ISOLATION; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME KINETICS; ENZYME SUBSTRATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IC 50; IN VITRO STUDY; INCUBATION TIME;

CYTOCHROME P-450 CYP3A; ECHINACEA; ENZYME INHIBITORS; HUMANS; PLANT EXTRACTS; RECOMBINANT PROTEINS; SAMBUCUS NIGRA; TESTOSTERONE;

ECHINACEA PURPUREA; SAMBUCUS; SAMBUCUS NIGRA;

EID: 84867849480     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4619     Document Type: Article

References (30)

1. Barrett B,. 2003. Medicinal properties of Echinacea: a critical review. Phytomedicine 10: 66-86.
2. Brodie RR, Hill HM,. 2002. Validation issues arising from the new FDA guidance for industry on bioanalytical method validation. Chromatographia 55: S91-S94.
3. Budzinski JW, Foster BC, Vandenhoek S, Arnason JT,. 2000. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 7: 273-282.
4. Cavaliere C, Rea P, Lynch ME, Blumenthal M,. 2010. Herbal supplement sales rise in all channels in 2009. HerbalGram 2010: 62-65.
5. Chan WK, Nguyen LT, Miller VP, Harris RZ,. 1998. Mechanism-based inactivation of human cytochrome P450 3A4 by grapefruit juice and red wine. Life Sci 62: PL135-PL142.
6. Copeland RA,. 2000. Enzymes. A Practical Introduction to Structure, Mechanism, and Data Analysis, 2nd edn. John Wiley & Sons, Inc.: New York.
7. Denisov IG, Frank DJ, Sligar SG,. 2009. Cooperative properties of cytochromes P450. Pharmacol Ther 124: 151-167.
8. Djuv A, Nilsen OG,. 2011. Aloe vera juice: IC(50) and dual mechanistic inhibition of CYP3A4 and CYP2D6. Phytother Res. DOI: 10.1002/ptr.3564.
9. Eisenberg DM, Davis RB, Ettner SL, et al., 1998. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. J Am Med Assoc 280: 1569-1575.
10. Engdal S, Nilsen OG,. 2009. In vitro inhibition of CYP3A4 by herbal remedies frequently used by cancer patients. Phytother Res 23: 906-912.
11. Ernst E,. 2002. St John's Wort supplements endanger the success of organ transplantation. Arch Surg 137: 316-319.
12. Freeman C, Spelman K,. 2008. A critical evaluation of drug interactions with Echinacea spp. Mol Nutr Food Res 52: 789-798.
13. Galetin A, Clarke SE, Houston JB,. 2003. Multisite kinetic analysis of interactions between prototypical CYP3A4 subgroup substrates: midazolam, testosterone, and nifedipine. Drug Metab Dispos 31: 1108-1116.
14. Hansen TS, Nilsen OG,. 2008. In vitro CYP3A4 metabolism: inhibition by Echinacea purpurea and choice of substrate for the evaluation of herbal inhibition. Basic Clin Pharmacol Toxicol 103: 445-449.
15. Hellum BH, Nilsen OG,. 2007. The in vitro inhibitory potential of trade herbal products on human CYP2D6-mediated metabolism and the influence of ethanol. Basic Clin Pharmacol Toxicol 101: 350-358.
16. Hellum BH, Nilsen OG,. 2008. In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products. Basic Clin Pharmacol Toxicol 102: 466-475.
17. Hellum BH, Tosse A, Hoybakk K, Thomsen M, Rohloff J, Nilsen OG,. 2010. Potent in vitro inhibition of CYP3A4 and P-glycoprotein by Rhodiola rosea. Planta Med 76: 331-338.
18. Izzo AA, Ernst E,. 2009. Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs 69: 1777-1798.
19. Modarai M, Gertsch J, Suter A, Heinrich M, Kortenkamp A,. 2007. Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content. J Pharm Pharmacol 59: 567-573.
20. Pan Y, Abd-Rashid BA, Ismail Z, et al., 2011. In vitro effects of active constituents and extracts of Orthosiphon stamineus on the activities of three major human cDNA-expressed cytochrome P450 enzymes. Chem Biol Interact 190: 1-8.
21. Pelkonen O, Turpeinen M, Hakkola J, Honkakoski P, Hukkanen J, Raunio H,. 2008. Inhibition and induction of human cytochrome P450 enzymes: current status. Arch Toxicol 82: 667-715.
22. Seden K, Dickinson L, Khoo S, Back D,. 2010. Grapefruit-drug interactions. Drugs 70: 2373-2407.
23. Singhuber J, Zhu M, Prinz S, Kopp B,. 2009. Aconitum in traditional Chinese medicine: a valuable drug or an unpredictable risk? J Ethnopharmacol 126: 18-30.
24. Stenesh J,. 1998. Biochemistry. Plenum Press: New York.
25. Strandell J, Neil A, Carlin G,. 2004. An approach to the in vitro evaluation of potential for cytochrome P450 enzyme inhibition from herbals and other natural remedies. Phytomedicine 11: 98-104.
26. Stupans I, Murray M, Kirlich A, Tuck KL, Hayball PJ,. 2001. Inactivation of cytochrome P450 by the food-derived complex phenol oleuropein. Food Chem Toxicol 39: 1119-1124.
27. Thole JM, Kraft TF, Sueiro LA, et al., 2006. A comparative evaluation of the anticancer properties of European and American elderberry fruits. J Med Food 9: 498-504.
28. Wills RBH, Stuart DL,. 1999. Alkylamide and chicoric acid levels in Echinacea purpurea grown in Australia. Food Chem 67: 385-388.
29. Zhou S, Koh HL, Gao Y, Gong ZY, Lee EJ,. 2004. Herbal bioactivation: the good, the bad and the ugly. Life Sci 74: 935-968.
30. Zhou SF, Xue CC, Yu XQ, Li C, Wang G,. 2007. Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring. Ther Drug Monit 29: 687-710.